Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Neuroimmune mechanisms of depression

Abstract

Current diagnosis of depression is based solely on behavioral symptomatology. The available US Food and Drug Administration–approved treatments for depression have come from serendipitous discovery and are ineffective in nearly 30–50% of patients, which is thought to reflect a lack of specificity in targeting underlying pathophysiological mechanisms. Recent evidence has identified depression-related disruptions in a neuroimmune axis that interfaces the immune system and CNS to control behavior. This Review examines the evidence in patients and in animal models of depression that demonstrates how the peripheral immune system acts on the brain to alter an individual's response to stress, ultimately contributing to their vulnerability to mood disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Circuits of the neuroimmune axis.
Figure 2: Inflammation and the brain.

Similar content being viewed by others

References

  1. Maes, M. et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34, 301–309 (1995).

    Article  CAS  PubMed  Google Scholar 

  2. Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446–457 (2010).

    Article  CAS  PubMed  Google Scholar 

  3. Hodes, G.E. et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. USA 111, 16136–16141 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Maes, M. et al. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J. Psychiatr. Res. 26, 125–134 (1992).

    Article  CAS  PubMed  Google Scholar 

  5. Fenton, W.S. & Stover, E.S. Mood disorders: cardiovascular and diabetes comorbidity. Curr. Opin. Psychiatry 19, 421–427 (2006).

    Article  PubMed  Google Scholar 

  6. Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L. & Brzeszcz, J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinol. Lett. 32, 7–24 (2011).

    CAS  PubMed  Google Scholar 

  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. (American Psychiatric Association, Arlington, Virginia, 2013).

  8. Krishnan, V. & Nestler, E.J. The molecular neurobiology of depression. Nature 455, 894–902 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Renault, P.F. et al. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147, 1577–1580 (1987).

    Article  CAS  PubMed  Google Scholar 

  10. Conversano, C. et al. Interferon alpha therapy in patients with chronic hepatitis C infection: quality of life and depression. Hematol. Rep. 7, 5632 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Maes, M. et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853–858 (1997).

    Article  CAS  PubMed  Google Scholar 

  12. Miller, G.E. et al. Greater inflammatory activity and blunted glucocorticoid signaling in monocytes of chronically stressed caregivers. Brain Behav. Immun. 41, 191–199 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Khandaker, G.M., Pearson, R.M., Zammit, S., Lewis, G. & Jones, P.B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71, 1121–1128 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Raison, C.L. et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70, 31–41 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Venkiteshwaran, A. Tocilizumab. MAbs 1, 432–438 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  16. Brietzke, E., Scheinberg, M. & Lafer, B. Therapeutic potential of interleukin-6 antagonism in bipolar disorder. Med. Hypotheses 76, 21–23 (2011).

    Article  CAS  PubMed  Google Scholar 

  17. Langley, R.G. et al. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J. Am. Acad. Dermatol. 63, 457–465 (2010).

    Article  CAS  PubMed  Google Scholar 

  18. Iyengar, R.L. et al. NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am. J. Med. 126, e1011–e1018 (2013).

    Article  CAS  Google Scholar 

  19. Köhler, O. et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71, 1381–1391 (2014).

    Article  PubMed  Google Scholar 

  20. Eyre, H.A., Air, T., Proctor, S., Rositano, S. & Baune, B.T. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 57, 11–16 (2015).

    Article  CAS  PubMed  Google Scholar 

  21. Warner-Schmidt, J.L., Vanover, K.E., Chen, E.Y., Marshall, J.J. & Greengard, P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. USA 108, 9262–9267 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Słuzewska, A. et al. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. NY Acad. Sci. 762, 474–476 (1995).

    Article  PubMed  Google Scholar 

  23. Jazayeri, S. et al. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Psychiatry Res. 178, 112–115 (2010).

    Article  CAS  PubMed  Google Scholar 

  24. Kubera, M. et al. Stimulatory effect of antidepressants on the production of IL-6. Int. Immunopharmacol. 4, 185–192 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. Murrough, J.W. et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 170, 1134–1142 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  26. De Kock, M., Loix, S. & Lavand'homme, P. Ketamine and peripheral inflammation. CNS Neurosci. Ther. 19, 403–410 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Scheiermann, C., Frenette, P.S. & Hidalgo, A. Regulation of leucocyte homeostasis in the circulation. Cardiovasc. Res. 107, 340–351 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hashimoto, D., Miller, J. & Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35, 323–335 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Spits, H. et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).

    Article  CAS  PubMed  Google Scholar 

  30. Frank, M.G., Weber, M.D., Watkins, L.R. & Maier, S.F. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun. 48, 1–7 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Portou, M.J., Baker, D., Abraham, D. & Tsui, J. The innate immune system, toll-like receptors and dermal wound healing: a review. Vascul. Pharmacol. 71, 31–36 (2015).

    Article  CAS  PubMed  Google Scholar 

  32. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).

    Article  CAS  PubMed  Google Scholar 

  33. Raz, E. Organ-specific regulation of innate immunity. Nat. Immunol. 8, 3–4 (2007).

    Article  CAS  PubMed  Google Scholar 

  34. Marino, F. & Cosentino, M. Adrenergic modulation of immune cells: an update. Amino Acids 45, 55–71 (2013).

    Article  CAS  PubMed  Google Scholar 

  35. Amsterdam, A., Tajima, K. & Sasson, R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem. Pharmacol. 64, 843–850 (2002).

    Article  CAS  PubMed  Google Scholar 

  36. Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98–101 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Tracey, K.J. Reflex control of immunity. Nat. Rev. Immunol. 9, 418–428 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Avitsur, R., Powell, N., Padgett, D.A. & Sheridan, J.F. Social interactions, stress, and immunity. Immunol. Allergy Clin. North Am. 29, 285–293 (2009).

    Article  PubMed  Google Scholar 

  39. Engler, H. et al. Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen. Psychoneuroendocrinology 33, 108–117 (2008).

    Article  CAS  PubMed  Google Scholar 

  40. Frank, M.G., Watkins, L.R. & Maier, S.F. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav. Immun. 33, 1–6 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Manz, M.G. & Boettcher, S. Emergency granulopoiesis. Nat. Rev. Immunol. 14, 302–314 (2014).

    Article  CAS  PubMed  Google Scholar 

  42. Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392–404 (2014).

    Article  CAS  PubMed  Google Scholar 

  43. Nakai, A., Hayano, Y., Furuta, F., Noda, M. & Suzuki, K. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J. Exp. Med. 211, 2583–2598 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ransohoff, R.M. & Brown, M.A. Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164–1171 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ajami, B., Bennett, J.L., Krieger, C., Tetzlaff, W. & Rossi, F.M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538–1543 (2007).

    Article  CAS  PubMed  Google Scholar 

  47. Greter, M. et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37, 1050–1060 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Nandi, S. et al. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 367, 100–113 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Shechter, R., London, A. & Schwartz, M. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat. Rev. Immunol. 13, 206–218 (2013).

    Article  CAS  PubMed  Google Scholar 

  50. Bulloch, K. et al. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508, 687–710 (2008).

    Article  PubMed  Google Scholar 

  51. Baruch, K. & Schwartz, M. CNS-specific T cells shape brain function via the choroid plexus. Brain Behav. Immun. 34, 11–16 (2013).

    Article  CAS  PubMed  Google Scholar 

  52. Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337–341 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318 (2005).

    Article  CAS  PubMed  Google Scholar 

  54. Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164–1178 (2007).

    Article  CAS  PubMed  Google Scholar 

  55. Paolicelli, R.C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458 (2011).

    Article  CAS  PubMed  Google Scholar 

  56. Limatola, C. & Ransohoff, R.M. Modulating neurotoxicity through CX3CL1/CX3CR1 signaling. Front. Cell. Neurosci. 8, 229 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Ajami, B., Bennett, J.L., Krieger, C., McNagny, K.M. & Rossi, F.M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142–1149 (2011).

    Article  CAS  PubMed  Google Scholar 

  58. Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533–1549 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Wohleb, E.S., Powell, N.D., Godbout, J.P. & Sheridan, J.F. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 33, 13820–13833 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Sawicki, C.M. et al. Social defeat promotes a reactive endothelium in a brain region-dependent manner with increased expression of key adhesion molecules, selectins and chemokines associated with the recruitment of myeloid cells to the brain. Neuroscience 302, 151–164 (2015).

    Article  CAS  PubMed  Google Scholar 

  61. Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Maes, M. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19, 11–38 (1995).

    Article  CAS  PubMed  Google Scholar 

  63. Smith, R.S. The macrophage theory of depression. Med. Hypotheses 35, 298–306 (1991).

    Article  CAS  PubMed  Google Scholar 

  64. Heidt, T. et al. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20, 754–758 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Brachman, R.A., Lehmann, M.L., Maric, D. & Herkenham, M. Lymphocytes from chronically stressed mice confer antidepressant-like effects to naive mice. J. Neurosci. 35, 1530–1538 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Pariante, C.M. The glucocorticoid receptor: part of the solution or part of the problem? J. Psychopharmacol. 20, 79–84 (2006).

    Article  PubMed  Google Scholar 

  67. Quan, N. et al. Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. J. Neuroimmunol. 137, 51–58 (2003).

    Article  CAS  PubMed  Google Scholar 

  68. Kollet, O. et al. Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors. Leukemia 27, 2006–2015 (2013).

    Article  CAS  PubMed  Google Scholar 

  69. Banks, W.A., Kastin, A.J. & Gutierrez, E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179, 53–56 (1994).

    Article  CAS  PubMed  Google Scholar 

  70. Banks, W.A., Kastin, A.J. & Broadwell, R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2, 241–248 (1995).

    Article  CAS  PubMed  Google Scholar 

  71. Gadient, R.A. & Otten, U.H. Interleukin-6 (IL-6)–a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52, 379–390 (1997).

    Article  CAS  PubMed  Google Scholar 

  72. Gordon, S. & Taylor, P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953–964 (2005).

    Article  CAS  PubMed  Google Scholar 

  73. Reader, B.F. et al. Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. Neuroscience 289, 429–442 (2015).

    Article  CAS  PubMed  Google Scholar 

  74. Gudmundsson, P. et al. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am. J. Geriatr. Psychiatry 15, 832–838 (2007).

    Article  PubMed  Google Scholar 

  75. Torres-Platas, S.G., Cruceanu, C., Chen, G.G., Turecki, G. & Mechawar, N. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav. Immun. 42, 50–59 (2014).

    Article  CAS  PubMed  Google Scholar 

  76. Varvel, N.H. et al. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc. Natl. Acad. Sci. USA 109, 18150–18155 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  77. Diniz, B.S., Butters, M.A., Albert, S.M., Dew, M.A. & Reynolds, C.F. III. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br. J. Psychiatry 202, 329–335 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  78. El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432–438 (2007).

    Article  CAS  PubMed  Google Scholar 

  79. Wang, D.D. & Bordey, A. The astrocyte odyssey. Prog. Neurobiol. 86, 342–367 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Meeuwsen, S., Persoon-Deen, C., Bsibsi, M., Ravid, R. & van Noort, J.M. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243–253 (2003).

    Article  PubMed  Google Scholar 

  81. Pang, Y., Cai, Z. & Rhodes, P.G. Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res. 914, 15–22 (2001).

    Article  CAS  PubMed  Google Scholar 

  82. Nagy, C. et al. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol. Psychiatry 20, 320–328 (2015).

    Article  CAS  PubMed  Google Scholar 

  83. Leventopoulos, M. et al. Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res. 1142, 119–126 (2007).

    Article  CAS  PubMed  Google Scholar 

  84. Tynan, R.J. et al. Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. Acta Neuropathol. 126, 75–91 (2013).

    Article  CAS  PubMed  Google Scholar 

  85. Steiner, J. et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation 8, 94 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Steiner, J. et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42, 151–157 (2008).

    Article  PubMed  Google Scholar 

  87. Setiawan, E. et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72, 268–275 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  88. Frank, M.G., Baratta, M.V., Sprunger, D.B., Watkins, L.R. & Maier, S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 21, 47–59 (2007).

    Article  CAS  PubMed  Google Scholar 

  89. Wohleb, E.S. et al. β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277–6288 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Frank, M.G., Miguel, Z.D., Watkins, L.R. & Maier, S.F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 24, 19–30 (2010).

    Article  CAS  PubMed  Google Scholar 

  91. Meagher, M.W. et al. Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. Brain Behav. Immun. 21, 1083–1095 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Koo, J.W., Russo, S.J., Ferguson, D., Nestler, E.J. & Duman, R.S. Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. USA 107, 2669–2674 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  93. Koo, J.W. & Duman, R.S. IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. USA 105, 751–756 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  94. Monje, F.J. et al. Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway. J. Neurosci. 31, 9075–9083 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W. & Kelley, K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Maes, M., Leonard, B.E., Myint, A.M., Kubera, M. & Verkerk, R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 702–721 (2011).

    Article  CAS  PubMed  Google Scholar 

  97. Garcia-Oscos, F. et al. The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling. Biol. Psychiatry 71, 574–582 (2012).

    Article  CAS  PubMed  Google Scholar 

  98. Beattie, E.C. et al. Control of synaptic strength by glial TNFα. Science 295, 2282–2285 (2002).

    Article  CAS  PubMed  Google Scholar 

  99. Rolls, A. et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 9, 1081–1088 (2007).

    Article  CAS  PubMed  Google Scholar 

  100. Santarelli, L. et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805–809 (2003).

    Article  CAS  PubMed  Google Scholar 

  101. Kettenmann, H., Kirchhoff, F. & Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron 77, 10–18 (2013).

    Article  CAS  PubMed  Google Scholar 

  102. Hawkes, C.A. & McLaurin, J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. USA 106, 1261–1266 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  103. Leinenga, G. & Gotz, J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Sci. Transl. Med. 7, 278ra233 (2015).

    Article  CAS  Google Scholar 

  104. Chen, S.K. et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141, 775–785 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Lin, S. et al. Comparison of the transcriptional landscapes between human and mouse tissues. Proc. Natl. Acad. Sci. USA 111, 17224–17229 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Mestas, J. & Hughes, C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731–2738 (2004).

    Article  CAS  PubMed  Google Scholar 

  107. Maes, M. et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10, 313–318 (1998).

    Article  CAS  PubMed  Google Scholar 

  108. Bluthé, R.M., Dantzer, R. & Kelley, K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 573, 318–320 (1992).

    Article  PubMed  Google Scholar 

  109. Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90–110 (2005).

    Article  CAS  PubMed  Google Scholar 

  110. Dalla, C., Pitychoutis, P.M., Kokras, N. & Papadopoulou-Daifoti, Z. Sex differences in animal models of depression and antidepressant response. Basic Clin. Pharmacol. Toxicol. 106, 226–233 (2010).

    Article  CAS  PubMed  Google Scholar 

  111. Krishnan, V., Berton, O. & Nestler, E. The use of animal models in psychiatric research and treatment. Am. J. Psychiatry 165, 1109 (2008).

    Article  PubMed  Google Scholar 

  112. Yang, C., Shirayama, Y., Zhang, J.C., Ren, Q. & Hashimoto, K. Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress. Acta Neuropsychiatr. 2015, 1–5 (2015).

    CAS  Google Scholar 

  113. Slattery, D.A. & Cryan, J.F. The ups and downs of modelling mood disorders in rodents. ILAR J. 55, 297–309 (2014).

    Article  CAS  PubMed  Google Scholar 

  114. Golden, S.A., Covington, H.E. III, Berton, O. & Russo, S.J. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183–1191 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Berton, O. et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864–868 (2006).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by US National Institute of Mental Health grants RO1 MH090264 (to S.J.R.) and RO1 MH104559 (to S.J.R. and M.M.), the Johnson & Johnson International Mental Health Research Organization Rising Star Award (to S.J.R.), an Irma T. Hirschl/Monique Weill-Caulier Trust Research Award (to S.J.R.), a Brain and Behavior Research Foundation Young Investigator Award (G.E.H.) and a Swiss National Science Foundation Early Postdoc Mobility fellowship (to V.K.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott J Russo.

Ethics declarations

Competing interests

Our previous work on IL-6 and depression was supported in part by a research grant from Janssen Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hodes, G., Kana, V., Menard, C. et al. Neuroimmune mechanisms of depression. Nat Neurosci 18, 1386–1393 (2015). https://doi.org/10.1038/nn.4113

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.4113

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing